| Bioactivity | LY2624803 is a 5-HT2A and histamine, H1 receptor antagonist[1][2]. |
| Name | LY2624803 |
| CAS | 879409-35-5 |
| Formula | C22H25N3O3 |
| Molar Mass | 379.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Abad VC, et al. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018;35(9):791-817. [2]. Zisapel N. Current Phase II investigational therapies for insomnia. Expert Opin Investig Drugs. 2015;24(3):401-411. |